Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rfx3
|
ENSMUSG00000040929.10 | regulatory factor X, 3 (influences HLA class II expression) |
Rfx1
|
ENSMUSG00000031706.6 | regulatory factor X, 1 (influences HLA class II expression) |
Rfx4
|
ENSMUSG00000020037.9 | regulatory factor X, 4 (influences HLA class II expression) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_84065741_84066498 | Rfx1 | 715 | 0.299554 | -0.29 | 2.5e-02 | Click! |
chr19_28008637_28008965 | Rfx3 | 1989 | 0.325245 | 0.68 | 1.7e-09 | Click! |
chr19_27906262_27906544 | Rfx3 | 5508 | 0.263082 | -0.53 | 1.2e-05 | Click! |
chr19_28009042_28009226 | Rfx3 | 1656 | 0.372643 | 0.49 | 7.7e-05 | Click! |
chr19_27907328_27907581 | Rfx3 | 6559 | 0.254965 | -0.48 | 1.0e-04 | Click! |
chr19_28006463_28006614 | Rfx3 | 4252 | 0.220132 | 0.46 | 2.3e-04 | Click! |
chr10_84756349_84757352 | Rfx4 | 788 | 0.694318 | 0.84 | 1.1e-16 | Click! |
chr10_84754760_84756248 | Rfx4 | 558 | 0.804531 | 0.83 | 4.6e-16 | Click! |
chr10_84757399_84758243 | Rfx4 | 1759 | 0.409908 | 0.77 | 6.3e-13 | Click! |
chr10_84758414_84759491 | Rfx4 | 2890 | 0.303816 | 0.66 | 8.6e-09 | Click! |
chr10_84759547_84760959 | Rfx4 | 1985 | 0.377275 | 0.59 | 8.2e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_129908592_129909805 | 73.18 |
Gm28196 |
predicted gene 28196 |
39370 |
0.15 |
chrX_136590440_136591154 | 72.07 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr18_60925301_60926809 | 67.00 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr10_81472751_81473777 | 64.17 |
Celf5 |
CUGBP, Elav-like family member 5 |
114 |
0.9 |
chr7_79505833_79506958 | 63.02 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr15_82255980_82257145 | 55.56 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chr15_25416075_25416310 | 53.01 |
Gm48957 |
predicted gene, 48957 |
1129 |
0.37 |
chr8_94994139_94995207 | 48.37 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr1_158364281_158364968 | 47.28 |
Astn1 |
astrotactin 1 |
2074 |
0.31 |
chr7_78882466_78883900 | 46.29 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr7_131966504_131967699 | 45.85 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr7_16959511_16960260 | 45.52 |
Pnmal1 |
PNMA-like 1 |
206 |
0.87 |
chr7_140080531_140082545 | 45.24 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr13_20472048_20472724 | 44.94 |
Elmo1 |
engulfment and cell motility 1 |
340 |
0.8 |
chr7_16982884_16983633 | 44.24 |
Gm42372 |
predicted gene, 42372 |
172 |
0.9 |
chr1_38847863_38848426 | 43.76 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
11433 |
0.16 |
chr3_107038303_107039010 | 43.74 |
AI504432 |
expressed sequence AI504432 |
848 |
0.54 |
chrX_136290697_136291204 | 43.74 |
n-R5s12 |
nuclear encoded rRNA 5S 12 |
13445 |
0.09 |
chr14_70627710_70629563 | 42.94 |
Dmtn |
dematin actin binding protein |
363 |
0.79 |
chrX_7919510_7921219 | 42.79 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr18_61737389_61738065 | 41.82 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
3370 |
0.17 |
chr7_19175632_19177533 | 41.82 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr9_21196536_21198489 | 41.71 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr15_98167479_98168718 | 40.87 |
Ccdc184 |
coiled-coil domain containing 184 |
940 |
0.4 |
chr7_44428985_44430475 | 40.74 |
Lrrc4b |
leucine rich repeat containing 4B |
712 |
0.43 |
chr19_5093987_5095591 | 40.24 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
3593 |
0.08 |
chr3_13946382_13947629 | 40.12 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr6_90809120_90810568 | 38.84 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
279 |
0.89 |
chr9_96729464_96730774 | 37.99 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
1083 |
0.47 |
chr7_128690432_128691249 | 37.90 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr3_88458101_88459325 | 37.64 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr11_69557185_69558010 | 37.58 |
Efnb3 |
ephrin B3 |
2608 |
0.12 |
chr5_113306771_113307936 | 37.54 |
Sgsm1 |
small G protein signaling modulator 1 |
3344 |
0.16 |
chr5_88583963_88584847 | 37.07 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr7_99267573_99269343 | 37.05 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr5_103210548_103211780 | 37.00 |
Mapk10 |
mitogen-activated protein kinase 10 |
109 |
0.98 |
chr3_108410436_108412210 | 36.73 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr2_65847409_65848267 | 36.64 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1983 |
0.36 |
chr8_123410787_123412789 | 36.63 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr5_70842845_70843343 | 36.09 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
477 |
0.9 |
chr8_45508499_45509041 | 35.34 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr11_102394791_102396113 | 35.32 |
Rundc3a |
RUN domain containing 3A |
2049 |
0.17 |
chr5_117492934_117494252 | 35.06 |
Gm42550 |
predicted gene 42550 |
27106 |
0.18 |
chr1_135579927_135581701 | 34.85 |
Gm4793 |
predicted gene 4793 |
3959 |
0.2 |
chr4_123013303_123014295 | 34.79 |
Trit1 |
tRNA isopentenyltransferase 1 |
2798 |
0.2 |
chr7_105568525_105569825 | 34.62 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
90 |
0.94 |
chr15_89532557_89533956 | 34.59 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
366 |
0.78 |
chr3_94483546_94484940 | 34.15 |
Celf3 |
CUGBP, Elav-like family member 3 |
84 |
0.93 |
chr2_164964539_164965035 | 34.11 |
Slc12a5 |
solute carrier family 12, member 5 |
3196 |
0.16 |
chr10_63026281_63027102 | 33.38 |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
2179 |
0.16 |
chr4_109342938_109343450 | 33.25 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr13_55483242_55484428 | 32.86 |
Dbn1 |
drebrin 1 |
134 |
0.9 |
chr6_88942597_88943050 | 32.78 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
7860 |
0.14 |
chr7_79507974_79509311 | 32.69 |
A330074H02Rik |
RIKEN cDNA A330074H02 gene |
1720 |
0.18 |
chr6_83185720_83187846 | 32.60 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr9_36821403_36822795 | 32.04 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
235 |
0.9 |
chr12_29528030_29528268 | 31.61 |
Myt1l |
myelin transcription factor 1-like |
235 |
0.94 |
chr16_14906219_14907566 | 30.90 |
Efcab1 |
EF-hand calcium binding domain 1 |
227 |
0.95 |
chr3_89226055_89227441 | 30.89 |
Mtx1 |
metaxin 1 |
304 |
0.42 |
chr1_93114883_93115774 | 30.82 |
Gm28086 |
predicted gene 28086 |
8775 |
0.13 |
chr15_77245294_77246216 | 30.46 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
169 |
0.94 |
chr17_90452868_90453681 | 30.08 |
Nrxn1 |
neurexin I |
1548 |
0.36 |
chr7_3304228_3304636 | 29.91 |
Prkcg |
protein kinase C, gamma |
787 |
0.41 |
chr4_45824678_45824840 | 29.46 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
2164 |
0.25 |
chr9_121403057_121404479 | 29.10 |
Trak1 |
trafficking protein, kinesin binding 1 |
290 |
0.91 |
chr11_89696426_89697261 | 28.86 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
2 |
0.99 |
chr10_20944672_20944857 | 28.66 |
Ahi1 |
Abelson helper integration site 1 |
7783 |
0.23 |
chr6_93911120_93911271 | 28.48 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
1309 |
0.53 |
chr7_16938553_16938795 | 28.08 |
Pnmal2 |
PNMA-like 2 |
6008 |
0.09 |
chr15_71727651_71728452 | 27.98 |
Fam135b |
family with sequence similarity 135, member B |
213 |
0.95 |
chr14_79445027_79445799 | 27.65 |
Kbtbd6 |
kelch repeat and BTB (POZ) domain containing 6 |
6422 |
0.15 |
chr11_87759834_87761999 | 26.79 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr18_43686487_43688415 | 26.52 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr2_164970287_164971705 | 26.52 |
Slc12a5 |
solute carrier family 12, member 5 |
2715 |
0.18 |
chr5_112228060_112229152 | 26.40 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
35 |
0.96 |
chr13_49319308_49320561 | 26.01 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
377 |
0.86 |
chr3_108535862_108537093 | 25.93 |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
18 |
0.92 |
chr7_4843778_4845015 | 25.86 |
Shisa7 |
shisa family member 7 |
300 |
0.77 |
chr12_5372822_5372973 | 25.66 |
Klhl29 |
kelch-like 29 |
2785 |
0.28 |
chr1_89549979_89550754 | 25.50 |
Gm25180 |
predicted gene, 25180 |
12994 |
0.18 |
chr5_120431744_120433119 | 25.41 |
Gm27199 |
predicted gene 27199 |
664 |
0.41 |
chr19_5097025_5098415 | 25.28 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
662 |
0.42 |
chr3_84304141_84305628 | 25.25 |
Trim2 |
tripartite motif-containing 2 |
75 |
0.98 |
chr11_80479429_80480178 | 25.16 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
2747 |
0.26 |
chr15_44751090_44751715 | 24.98 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
878 |
0.47 |
chr7_4546391_4547839 | 24.93 |
Syt5 |
synaptotagmin V |
142 |
0.89 |
chr3_118674266_118674774 | 24.44 |
Dpyd |
dihydropyrimidine dehydrogenase |
112334 |
0.06 |
chr10_60115211_60116020 | 24.21 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9147 |
0.19 |
chr8_13705592_13706140 | 23.93 |
Cfap97d2 |
CFAP97 domain containing 2 |
23 |
0.97 |
chr3_146769678_146770812 | 23.72 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
16 |
0.98 |
chr12_56829329_56829736 | 23.64 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
54172 |
0.14 |
chr10_34316245_34317506 | 23.52 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
3192 |
0.16 |
chr11_76466993_76468433 | 23.43 |
Abr |
active BCR-related gene |
585 |
0.77 |
chrX_99141766_99142562 | 23.39 |
Efnb1 |
ephrin B1 |
4033 |
0.29 |
chr5_48889724_48890282 | 23.34 |
Kcnip4 |
Kv channel interacting protein 4 |
446 |
0.76 |
chr7_3389818_3390428 | 23.07 |
Gm44257 |
predicted gene, 44257 |
43 |
0.88 |
chr1_42539071_42540720 | 23.05 |
Gm37047 |
predicted gene, 37047 |
48082 |
0.15 |
chr10_79803572_79804215 | 23.05 |
Palm |
paralemmin |
2125 |
0.12 |
chr15_87546913_87547689 | 22.99 |
Tafa5 |
TAFA chemokine like family member 5 |
3002 |
0.41 |
chr8_70316808_70317410 | 22.94 |
Cers1 |
ceramide synthase 1 |
1241 |
0.28 |
chr3_127225406_127226570 | 22.89 |
Ank2 |
ankyrin 2, brain |
55 |
0.97 |
chr2_97478080_97479309 | 22.64 |
Lrrc4c |
leucine rich repeat containing 4C |
10605 |
0.3 |
chr7_126950022_126951260 | 22.59 |
Sez6l2 |
seizure related 6 homolog like 2 |
57 |
0.89 |
chr2_152375536_152376922 | 22.50 |
Nrsn2 |
neurensin 2 |
409 |
0.66 |
chr12_70367436_70368272 | 22.25 |
Trim9 |
tripartite motif-containing 9 |
20240 |
0.17 |
chr11_87763521_87764892 | 22.13 |
Tspoap1 |
TSPO associated protein 1 |
525 |
0.59 |
chr6_13835523_13837039 | 22.02 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr3_89245218_89245909 | 21.91 |
Trim46 |
tripartite motif-containing 46 |
309 |
0.49 |
chr13_84060966_84061181 | 21.81 |
Gm17750 |
predicted gene, 17750 |
3699 |
0.27 |
chr10_109832096_109833441 | 21.74 |
Nav3 |
neuron navigator 3 |
453 |
0.9 |
chr12_29534253_29535510 | 21.72 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr7_139894561_139895585 | 21.65 |
Kndc1 |
kinase non-catalytic C-lobe domain (KIND) containing 1 |
234 |
0.88 |
chr6_121130275_121131149 | 21.65 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
287 |
0.88 |
chr16_94995704_94996004 | 21.63 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
1398 |
0.55 |
chr5_24596283_24597467 | 21.51 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
26 |
0.95 |
chr11_6604576_6606131 | 21.45 |
Nacad |
NAC alpha domain containing |
700 |
0.46 |
chr10_42860045_42861117 | 21.37 |
Scml4 |
Scm polycomb group protein like 4 |
38 |
0.96 |
chr10_112160017_112160369 | 21.22 |
Glipr1l3 |
GLI pathogenesis-related 1 like 3 |
134 |
0.94 |
chr13_69933620_69934106 | 21.17 |
4933416O17Rik |
RIKEN cDNA 4933416O17 gene |
25970 |
0.17 |
chr6_83171941_83172736 | 21.05 |
Gm15624 |
predicted gene 15624 |
216 |
0.83 |
chr2_83940853_83941570 | 20.75 |
Zswim2 |
zinc finger SWIM-type containing 2 |
15 |
0.96 |
chr14_52004234_52004767 | 20.68 |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
2 |
0.94 |
chr11_101462487_101463439 | 20.43 |
Rnd2 |
Rho family GTPase 2 |
2036 |
0.12 |
chr10_94905327_94906276 | 20.42 |
Plxnc1 |
plexin C1 |
16856 |
0.18 |
chr3_86844929_86845442 | 20.29 |
Gm37025 |
predicted gene, 37025 |
19307 |
0.17 |
chr4_120364846_120365136 | 20.26 |
Scmh1 |
sex comb on midleg homolog 1 |
40290 |
0.16 |
chr3_84954855_84955348 | 20.01 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
2955 |
0.37 |
chr9_75610075_75610368 | 20.01 |
Tmod2 |
tropomodulin 2 |
854 |
0.52 |
chr10_80298461_80300404 | 19.90 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr2_66177971_66179189 | 19.82 |
Gm13618 |
predicted gene 13618 |
9256 |
0.18 |
chr7_78885666_78887958 | 19.76 |
Mir7-2 |
microRNA 7-2 |
1465 |
0.28 |
chr8_22805144_22805568 | 19.59 |
Ap3m2 |
adaptor-related protein complex 3, mu 2 subunit |
246 |
0.65 |
chr2_21918033_21918756 | 19.46 |
Gm24886 |
predicted gene, 24886 |
123339 |
0.06 |
chr5_125675464_125676085 | 19.41 |
Tmem132b |
transmembrane protein 132B |
53286 |
0.15 |
chr7_30444318_30445408 | 19.35 |
Aplp1 |
amyloid beta (A4) precursor-like protein 1 |
267 |
0.76 |
chr4_90437640_90438299 | 19.33 |
Gm12635 |
predicted gene 12635 |
14905 |
0.24 |
chr7_18949615_18951696 | 19.24 |
Nova2 |
NOVA alternative splicing regulator 2 |
24767 |
0.07 |
chr12_66470263_66470830 | 19.06 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
512 |
0.76 |
chr3_89759596_89761036 | 19.00 |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
3085 |
0.15 |
chr7_142091808_142093330 | 18.99 |
Dusp8 |
dual specificity phosphatase 8 |
2703 |
0.11 |
chr19_53852572_53852887 | 18.88 |
Rbm20 |
RNA binding motif protein 20 |
9519 |
0.15 |
chr2_17839163_17839519 | 18.88 |
Gm13323 |
predicted gene 13323 |
41357 |
0.17 |
chr2_127520770_127522413 | 18.82 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
221 |
0.89 |
chr1_6729327_6730832 | 18.79 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr1_66321652_66322390 | 18.52 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr15_74536612_74536909 | 18.48 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
3637 |
0.22 |
chr13_97746854_97747895 | 18.45 |
5330416C01Rik |
RIKEN cDNA 5330416C01 gene |
5 |
0.97 |
chr11_80622213_80623518 | 18.43 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
113759 |
0.05 |
chr11_103961035_103962020 | 18.43 |
Arf2 |
ADP-ribosylation factor 2 |
5212 |
0.22 |
chr7_29314313_29315903 | 18.36 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
45 |
0.96 |
chr1_172016118_172017482 | 18.34 |
Vangl2 |
VANGL planar cell polarity 2 |
7771 |
0.14 |
chr16_42444471_42445397 | 18.16 |
Gap43 |
growth associated protein 43 |
104283 |
0.07 |
chr13_36282740_36283315 | 18.13 |
Gm48766 |
predicted gene, 48766 |
30668 |
0.17 |
chr8_12165421_12166234 | 18.13 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
112992 |
0.05 |
chr4_138724436_138725694 | 18.09 |
Ubxn10 |
UBX domain protein 10 |
156 |
0.63 |
chr2_140666876_140668088 | 18.04 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
3918 |
0.37 |
chr5_142964424_142964601 | 18.00 |
Fscn1 |
fascin actin-bundling protein 1 |
21 |
0.97 |
chr7_51621596_51622924 | 17.97 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr13_119753686_119754726 | 17.93 |
Nim1k |
NIM1 serine/threonine protein kinase |
1676 |
0.22 |
chr5_137734408_137735271 | 17.89 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
4879 |
0.1 |
chr19_6501834_6503156 | 17.87 |
Nrxn2 |
neurexin II |
4660 |
0.14 |
chrX_136313431_136314232 | 17.79 |
Nsa2-ps2 |
NSA2 ribosome biogenesis homolog, pseudogene 2 |
14468 |
0.08 |
chr7_4123599_4125108 | 17.75 |
Ttyh1 |
tweety family member 1 |
136 |
0.91 |
chr12_11882344_11882726 | 17.73 |
Tubb2a-ps2 |
tubulin, beta 2a, pseudogene 2 |
128 |
0.97 |
chr6_124863054_124863787 | 17.70 |
Gpr162 |
G protein-coupled receptor 162 |
292 |
0.76 |
chr6_48536975_48537630 | 17.59 |
1700026J14Rik |
RIKEN cDNA 1700026J14 gene |
172 |
0.63 |
chr11_34316975_34317490 | 17.58 |
Insyn2b |
inhibitory synaptic factor family member 2B |
2410 |
0.28 |
chr14_60384879_60385447 | 17.54 |
Amer2 |
APC membrane recruitment 2 |
6877 |
0.22 |
chr2_71749562_71750513 | 17.50 |
Gm13662 |
predicted gene 13662 |
112 |
0.93 |
chr9_61384680_61386184 | 17.50 |
Tle3 |
transducin-like enhancer of split 3 |
9903 |
0.19 |
chr1_62934093_62934601 | 17.43 |
Gm44468 |
predicted gene, 44468 |
91395 |
0.06 |
chr2_163438209_163439457 | 17.35 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr1_172201946_172204322 | 17.24 |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
3319 |
0.13 |
chr11_69412589_69413874 | 17.20 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
444 |
0.64 |
chr5_103161429_103161791 | 17.17 |
Mapk10 |
mitogen-activated protein kinase 10 |
44319 |
0.17 |
chr14_64199706_64200619 | 17.16 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
83848 |
0.07 |
chr6_5403248_5403804 | 17.15 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
13099 |
0.25 |
chr1_42691569_42692627 | 17.11 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr3_88221230_88222236 | 17.08 |
Gm3764 |
predicted gene 3764 |
931 |
0.32 |
chr2_32428080_32429746 | 16.94 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr8_95000676_95001112 | 16.90 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
13 |
0.96 |
chr8_84934799_84937325 | 16.80 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1282 |
0.19 |
chr4_130570923_130571689 | 16.74 |
Nkain1 |
Na+/K+ transporting ATPase interacting 1 |
2660 |
0.34 |
chr12_3887277_3888220 | 16.64 |
Dnmt3a |
DNA methyltransferase 3A |
2299 |
0.27 |
chr11_80483839_80484693 | 16.62 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
7210 |
0.19 |
chr2_157049731_157050264 | 16.59 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
9758 |
0.14 |
chr9_91413974_91414551 | 16.55 |
Gm29478 |
predicted gene 29478 |
9788 |
0.15 |
chr18_34982860_34983365 | 16.53 |
Gm36037 |
predicted gene, 36037 |
142 |
0.94 |
chr7_78989959_78991095 | 16.52 |
Gm26633 |
predicted gene, 26633 |
62796 |
0.08 |
chr15_78429019_78429662 | 16.49 |
Kctd17 |
potassium channel tetramerisation domain containing 17 |
350 |
0.76 |
chr11_117394275_117395481 | 16.47 |
Gm11729 |
predicted gene 11729 |
19511 |
0.13 |
chr3_108405224_108406300 | 16.47 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
3173 |
0.12 |
chr4_148173785_148174480 | 16.44 |
Fbxo2 |
F-box protein 2 |
13511 |
0.1 |
chr14_65403907_65404762 | 16.42 |
Zfp395 |
zinc finger protein 395 |
8654 |
0.19 |
chr7_16957023_16957245 | 16.33 |
Pnmal1 |
PNMA-like 1 |
2545 |
0.13 |
chr2_54437392_54437697 | 16.33 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
1053 |
0.65 |
chr10_78396162_78396676 | 16.30 |
Gm10146 |
predicted gene 10146 |
3099 |
0.11 |
chr13_24521413_24521861 | 16.24 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
20112 |
0.17 |
chr18_56287729_56288226 | 16.21 |
Gm50385 |
predicted gene, 50385 |
3125 |
0.3 |
chr14_100459027_100460331 | 16.17 |
6330576A10Rik |
RIKEN cDNA 6330576A10 gene |
256 |
0.93 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.9 | 64.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
10.7 | 32.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
10.0 | 40.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
9.8 | 29.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
7.4 | 29.6 | GO:0030035 | microspike assembly(GO:0030035) |
7.3 | 22.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
6.9 | 62.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
5.8 | 17.3 | GO:0021586 | pons maturation(GO:0021586) |
5.7 | 17.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
5.5 | 22.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
5.4 | 21.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
5.3 | 58.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
5.3 | 31.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
4.8 | 14.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
4.8 | 14.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
4.4 | 8.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
4.4 | 66.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
4.2 | 29.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
4.0 | 8.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.0 | 12.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.8 | 22.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.7 | 33.1 | GO:0050957 | equilibrioception(GO:0050957) |
3.7 | 14.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.6 | 18.2 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
3.5 | 38.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
3.5 | 13.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
3.4 | 13.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
3.3 | 9.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.3 | 29.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
3.1 | 25.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
3.1 | 12.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
3.1 | 9.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
3.0 | 9.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.0 | 26.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
2.9 | 2.9 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.9 | 8.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.9 | 17.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.9 | 23.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.9 | 8.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.7 | 2.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.7 | 41.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.7 | 40.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.7 | 13.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.6 | 7.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.6 | 43.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.5 | 10.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.5 | 14.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
2.5 | 19.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
2.4 | 9.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
2.3 | 6.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.3 | 13.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.3 | 13.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.3 | 6.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.3 | 22.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.2 | 2.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
2.2 | 26.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
2.1 | 10.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.0 | 6.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
2.0 | 5.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.0 | 11.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.0 | 11.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.9 | 11.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.9 | 3.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.8 | 11.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.7 | 7.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.7 | 31.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.7 | 6.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.7 | 17.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.7 | 5.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.7 | 45.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
1.7 | 5.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.6 | 4.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.6 | 6.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.6 | 4.8 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.6 | 6.4 | GO:0014028 | notochord formation(GO:0014028) |
1.6 | 1.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.6 | 33.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.6 | 4.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.6 | 9.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.6 | 7.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.6 | 26.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.6 | 3.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.5 | 4.6 | GO:0021564 | vagus nerve development(GO:0021564) |
1.5 | 4.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.5 | 4.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.4 | 2.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.4 | 14.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.4 | 9.9 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 2.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 5.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.4 | 1.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.4 | 4.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
1.4 | 8.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.3 | 4.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.3 | 52.4 | GO:0046847 | filopodium assembly(GO:0046847) |
1.3 | 3.9 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.3 | 12.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.3 | 5.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.3 | 3.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 3.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.3 | 3.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.3 | 7.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.3 | 1.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.2 | 2.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.2 | 2.5 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.2 | 2.4 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
1.2 | 4.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.2 | 2.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.2 | 14.3 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.2 | 2.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.2 | 14.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.2 | 4.6 | GO:0060174 | limb bud formation(GO:0060174) |
1.2 | 31.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.1 | 65.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
1.1 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
1.1 | 3.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.1 | 2.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.1 | 8.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.1 | 3.3 | GO:0097061 | dendritic spine organization(GO:0097061) |
1.1 | 5.5 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.1 | 4.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.1 | 5.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 1.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 5.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.1 | 3.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.1 | 24.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.1 | 5.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.1 | 7.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.1 | 16.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.1 | 16.9 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
1.1 | 19.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 3.2 | GO:0032439 | endosome localization(GO:0032439) |
1.0 | 18.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.0 | 43.9 | GO:0008542 | visual learning(GO:0008542) |
1.0 | 9.3 | GO:0060736 | prostate gland growth(GO:0060736) |
1.0 | 56.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.0 | 16.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.0 | 4.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 17.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.0 | 3.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.0 | 1.0 | GO:0097369 | sodium ion import(GO:0097369) |
1.0 | 5.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.0 | 33.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
1.0 | 13.8 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.0 | 2.0 | GO:0003192 | mitral valve formation(GO:0003192) |
1.0 | 4.9 | GO:0070842 | aggresome assembly(GO:0070842) |
1.0 | 2.0 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.0 | 44.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.0 | 3.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 3.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 1.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.9 | 2.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 10.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.9 | 1.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.9 | 7.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.9 | 1.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.9 | 7.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 2.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.9 | 4.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 2.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 4.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.9 | 2.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 1.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.9 | 0.9 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.9 | 15.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 31.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.8 | 9.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.8 | 6.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.8 | 1.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.8 | 3.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 7.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.8 | 2.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.8 | 2.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.8 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 2.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.8 | 9.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.8 | 0.8 | GO:0098597 | observational learning(GO:0098597) |
0.8 | 0.8 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.8 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 1.6 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.8 | 6.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.8 | 2.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 6.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.8 | 0.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.8 | 2.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 0.8 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.8 | 2.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 47.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.8 | 10.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.7 | 9.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.7 | 1.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.2 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.7 | 2.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 1.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.7 | 2.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.7 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.7 | 2.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.7 | 2.2 | GO:0015747 | urate transport(GO:0015747) |
0.7 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 2.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.7 | 4.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 4.1 | GO:0001964 | startle response(GO:0001964) |
0.7 | 20.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.7 | 23.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.7 | 8.9 | GO:0006415 | translational termination(GO:0006415) |
0.7 | 2.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 7.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.7 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.7 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 2.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 2.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 0.7 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.7 | 11.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.7 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 1.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 2.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 37.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.6 | 7.7 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 2.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 0.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.6 | 1.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 3.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 0.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 0.6 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) regulation of eosinophil degranulation(GO:0043309) |
0.6 | 0.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.6 | 0.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 1.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.6 | 1.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 4.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.6 | 0.6 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.6 | 0.6 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 2.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.6 | 1.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 5.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.6 | 1.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.6 | 0.6 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.6 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 4.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 8.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 2.8 | GO:0021756 | striatum development(GO:0021756) |
0.6 | 1.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.6 | 1.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.6 | 1.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 2.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.6 | 12.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.6 | 2.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.5 | 3.3 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.5 | 2.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.5 | 1.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.5 | 3.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 4.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 2.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.5 | 5.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 2.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 1.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.5 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 2.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 4.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.5 | 5.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.5 | 1.5 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 3.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 2.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 1.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.5 | 1.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.5 | 2.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 11.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.5 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 1.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 5.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 1.9 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 4.7 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 4.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.5 | 1.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 3.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.5 | 7.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 3.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 4.6 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 5.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 1.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 6.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 0.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 2.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 4.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.4 | 1.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 0.4 | GO:0014044 | Schwann cell development(GO:0014044) |
0.4 | 8.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.4 | 1.8 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.4 | 0.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 7.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 0.4 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 0.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 0.9 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.4 | 2.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 0.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 3.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 26.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 1.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 24.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 3.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 1.6 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 1.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 7.6 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.4 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 2.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 2.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 1.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 4.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 2.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 4.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.4 | 1.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 0.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 2.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 2.7 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.4 | 2.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 3.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 8.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 0.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.4 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.4 | 0.7 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.4 | 1.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 2.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 0.4 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 3.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 4.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 1.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.4 | 2.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 0.7 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 2.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.3 | 1.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 4.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 6.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 1.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.3 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 1.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.3 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 6.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 3.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 2.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.7 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.3 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.3 | 2.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 4.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 1.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 2.9 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.3 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.3 | 5.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 9.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 6.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 1.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 1.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 4.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.3 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 9.6 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.3 | 0.9 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 18.7 | GO:0007411 | axon guidance(GO:0007411) |
0.3 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.3 | 1.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 0.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 0.6 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.3 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 9.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 2.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 2.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.3 | 0.9 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 0.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.3 | 3.8 | GO:0032094 | response to food(GO:0032094) |
0.3 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 8.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.9 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.3 | 0.3 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.3 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.6 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 4.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 0.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.3 | 15.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.9 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.3 | 4.3 | GO:0030819 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.3 | 0.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.3 | 0.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 2.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.3 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 2.8 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 1.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.1 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 0.8 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.4 | GO:0042737 | drug catabolic process(GO:0042737) |
0.3 | 0.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 1.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 4.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 4.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 6.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.3 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.5 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 2.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 0.8 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 1.3 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 1.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 1.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.3 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 4.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 1.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 1.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 11.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.2 | 1.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 2.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 7.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 1.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 1.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.7 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 1.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 7.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.2 | 10.6 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 5.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 1.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 11.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 4.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 1.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 1.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 2.1 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 1.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 2.5 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 13.7 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.2 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 3.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 2.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.4 | GO:0048588 | developmental cell growth(GO:0048588) |
0.2 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 1.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 10.6 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.2 | 0.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.4 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.2 | 0.6 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.8 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 1.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 1.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 1.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.2 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 2.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.3 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.2 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 1.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 3.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 3.1 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.2 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.3 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 1.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 2.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.5 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
0.2 | 0.8 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 2.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 1.6 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.3 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 1.6 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.6 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.1 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 1.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 2.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.5 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.3 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.7 | GO:0072677 | eosinophil migration(GO:0072677) |
0.1 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.5 | GO:0050802 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 7.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.3 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 1.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 4.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.5 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 1.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 9.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.2 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 1.5 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.1 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.8 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.1 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 2.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.5 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 3.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.1 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
0.1 | 0.3 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 1.5 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 1.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.4 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.8 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0036314 | response to sterol(GO:0036314) |
0.1 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.1 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.5 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.1 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.2 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 1.9 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.7 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 2.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.3 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.7 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 1.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 1.3 | GO:0006275 | regulation of DNA replication(GO:0006275) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.2 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.4 | GO:0015844 | monoamine transport(GO:0015844) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.3 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet activation(GO:0010544) negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.0 | 0.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 48.0 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.2 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.0 | 0.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.7 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.0 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.0 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 1.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.6 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.0 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.0 | 0.0 | GO:0009176 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.0 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.0 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.6 | 55.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
10.9 | 32.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
7.5 | 30.0 | GO:0044308 | axonal spine(GO:0044308) |
6.2 | 31.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
6.0 | 18.0 | GO:0044393 | microspike(GO:0044393) |
5.8 | 52.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
5.7 | 17.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.4 | 17.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
4.3 | 21.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.1 | 32.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
4.0 | 15.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
3.8 | 26.7 | GO:0071437 | invadopodium(GO:0071437) |
3.5 | 24.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.1 | 56.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
2.9 | 20.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.8 | 16.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.7 | 37.1 | GO:0071565 | nBAF complex(GO:0071565) |
2.2 | 11.2 | GO:0097433 | dense body(GO:0097433) |
2.0 | 8.1 | GO:0030673 | axolemma(GO:0030673) |
2.0 | 51.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.9 | 7.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.8 | 16.3 | GO:0036128 | CatSper complex(GO:0036128) |
1.8 | 8.9 | GO:0005579 | membrane attack complex(GO:0005579) |
1.8 | 31.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.7 | 12.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.7 | 23.8 | GO:0031045 | dense core granule(GO:0031045) |
1.7 | 1.7 | GO:0097342 | ripoptosome(GO:0097342) |
1.7 | 26.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.6 | 8.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.6 | 9.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 12.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.6 | 6.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.5 | 12.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.5 | 6.1 | GO:0008091 | spectrin(GO:0008091) |
1.5 | 16.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.5 | 4.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 100.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.4 | 34.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.4 | 233.7 | GO:0060076 | excitatory synapse(GO:0060076) |
1.4 | 57.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 12.4 | GO:0005869 | dynactin complex(GO:0005869) |
1.3 | 5.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.2 | 13.4 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 3.5 | GO:0032280 | symmetric synapse(GO:0032280) |
1.1 | 1.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.1 | 9.6 | GO:0036156 | inner dynein arm(GO:0036156) |
1.0 | 7.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 3.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.0 | 5.0 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 3.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 18.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.0 | 3.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.9 | 15.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.9 | 18.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 1.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.9 | 10.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 7.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 3.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.8 | 3.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 3.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 6.1 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 7.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 35.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.7 | 2.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 6.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 3.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 6.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.7 | 2.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 3.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 4.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 8.4 | GO:0001741 | XY body(GO:0001741) |
0.6 | 4.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 1.8 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 6.2 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 5.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 4.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 4.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.6 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 4.2 | GO:0036157 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
0.5 | 6.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 0.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.5 | 9.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 3.1 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 3.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 2.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 140.6 | GO:0005874 | microtubule(GO:0005874) |
0.5 | 9.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.5 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 2.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 33.1 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 3.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 4.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 24.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 3.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 20.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 1.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 3.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 15.5 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 2.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 2.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.4 | 2.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 5.5 | GO:0043005 | neuron projection(GO:0043005) |
0.4 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 15.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.4 | 4.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 1.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 1.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 54.0 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 5.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 1.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 4.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 5.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 3.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 1.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 0.9 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 8.4 | GO:0099503 | secretory vesicle(GO:0099503) |
0.3 | 15.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 1.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 3.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 39.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 7.5 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 2.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 31.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 2.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 2.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 22.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 12.3 | GO:0005814 | centriole(GO:0005814) |
0.3 | 5.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 10.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 7.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 66.8 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 5.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 1.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 18.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 1.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 4.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.7 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.2 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.9 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 5.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 5.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 2.6 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 6.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 9.1 | GO:0042995 | cell projection(GO:0042995) |
0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.9 | GO:0044297 | cell body(GO:0044297) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 14.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 3.8 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 28.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.2 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 10.8 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 35.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.2 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 2.5 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 2.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 11.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 2.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 6.0 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.2 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 4.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 2.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 9.8 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 3.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 4.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 8.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 3.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 15.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 15.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 1.1 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 1.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 7.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 6.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.7 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 3.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 3.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.1 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 2.6 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 1.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 6.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 3.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 12.0 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 2.2 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 134.2 | GO:0005886 | plasma membrane(GO:0005886) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 138.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 6.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 7.7 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 1.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 1.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 64.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 36.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.7 | 23.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
9.5 | 28.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
8.5 | 42.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
8.4 | 25.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.8 | 23.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
6.0 | 23.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
5.5 | 22.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
5.0 | 64.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
5.0 | 9.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.7 | 14.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.5 | 39.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.4 | 13.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
3.3 | 16.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.2 | 9.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.1 | 66.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
3.1 | 21.9 | GO:0018646 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
3.1 | 12.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.0 | 17.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.9 | 11.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.7 | 32.8 | GO:0048156 | tau protein binding(GO:0048156) |
2.6 | 77.7 | GO:0050699 | WW domain binding(GO:0050699) |
2.6 | 25.8 | GO:0005522 | profilin binding(GO:0005522) |
2.6 | 10.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.5 | 42.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.4 | 12.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.4 | 11.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
2.1 | 15.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.1 | 18.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.1 | 10.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.1 | 6.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
2.0 | 8.1 | GO:0015265 | urea channel activity(GO:0015265) |
2.0 | 6.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.0 | 6.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.9 | 9.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.7 | 8.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.7 | 16.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.7 | 5.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 44.8 | GO:0030507 | spectrin binding(GO:0030507) |
1.6 | 42.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.6 | 37.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.6 | 20.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.6 | 4.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.5 | 18.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.5 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.5 | 41.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.5 | 6.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 7.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.5 | 4.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.4 | 27.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.4 | 11.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.4 | 6.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.3 | 3.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.3 | 44.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.3 | 19.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.3 | 5.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.3 | 31.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.2 | 13.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.2 | 3.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.2 | 4.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.2 | 57.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.1 | 5.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 6.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 5.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 5.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 3.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 6.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.0 | 6.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.0 | 68.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 2.0 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.0 | 3.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 11.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.9 | 3.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 10.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 19.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.9 | 6.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.9 | 5.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.8 | 3.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 2.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.8 | 2.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.8 | 2.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 4.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 5.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 2.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 30.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.8 | 3.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 3.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 10.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.7 | 27.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 3.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 4.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 6.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 12.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 5.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 3.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 5.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 1.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 9.6 | GO:0045502 | dynein binding(GO:0045502) |
0.6 | 95.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.6 | 10.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 3.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 3.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 3.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 14.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 2.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 5.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 2.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 1.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 6.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 1.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 4.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 3.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 2.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 13.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 5.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 10.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 1.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 10.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 18.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.5 | 6.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 2.6 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.5 | 19.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 11.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.5 | 8.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 21.5 | GO:0017095 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.5 | 1.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 4.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 3.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 1.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 2.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 3.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 1.9 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.5 | 3.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 10.2 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 4.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 6.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 41.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 5.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 18.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 2.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 11.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 4.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 1.3 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 3.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 5.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 21.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 2.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 8.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 17.3 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 0.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 2.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 0.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.6 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 3.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 3.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.4 | 25.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 8.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 2.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 1.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 8.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 1.5 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 1.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.4 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 3.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 8.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 23.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 1.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 17.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 7.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 6.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 2.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 2.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 13.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 3.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 3.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 41.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 2.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 6.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 2.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 8.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 3.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 0.9 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.3 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 2.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 2.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 2.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.3 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.6 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 2.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 6.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 4.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.8 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 0.3 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 2.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 0.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 2.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.7 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 3.2 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 4.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 4.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 3.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 1.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 2.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 3.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 2.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 2.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 111.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 4.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 1.0 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 8.9 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 5.0 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 69.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 2.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 1.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 3.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 1.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 5.4 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 21.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 2.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 6.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.4 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 1.9 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 9.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 5.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.4 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 2.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 7.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 3.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 3.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 1.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 6.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 2.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 3.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 1.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.0 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 3.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 61.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 2.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 12.5 | GO:0005543 | phospholipid binding(GO:0005543) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 9.6 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.1 | 3.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.5 | GO:0008951 | dihydrolipoamide branched chain acyltransferase activity(GO:0004147) sterol O-acyltransferase activity(GO:0004772) palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity(GO:0008951) serine O-acyltransferase activity(GO:0016412) O-succinyltransferase activity(GO:0016750) sinapoyltransferase activity(GO:0016752) O-sinapoyltransferase activity(GO:0016753) peptidyl-lysine N6-myristoyltransferase activity(GO:0018030) peptidyl-lysine N6-palmitoyltransferase activity(GO:0018031) benzoyl acetate-CoA thiolase activity(GO:0018711) 3-hydroxybutyryl-CoA thiolase activity(GO:0018712) 3-ketopimelyl-CoA thiolase activity(GO:0018713) N-palmitoyltransferase activity(GO:0019105) acyl-CoA N-acyltransferase activity(GO:0019186) protein-cysteine S-myristoyltransferase activity(GO:0019705) glucosaminyl-phosphotidylinositol O-acyltransferase activity(GO:0032216) ergosterol O-acyltransferase activity(GO:0034737) lanosterol O-acyltransferase activity(GO:0034738) naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity(GO:0034848) 2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity(GO:0034851) 2-methylhexanoyl-CoA C-acetyltransferase activity(GO:0034915) butyryl-CoA 2-C-propionyltransferase activity(GO:0034919) 2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity(GO:0034945) L-2-aminoadipate N-acetyltransferase activity(GO:0043741) keto acid formate lyase activity(GO:0043806) Ras palmitoyltransferase activity(GO:0043849) azetidine-2-carboxylic acid acetyltransferase activity(GO:0046941) peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) acetyl-CoA:L-lysine N6-acetyltransferase(GO:0090595) |
0.1 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 5.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.1 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 1.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.2 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0022884 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.2 | GO:0018542 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.5 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 7.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 1.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 4.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 5.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 54.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 6.4 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 3.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.4 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0043140 | four-way junction helicase activity(GO:0009378) ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 2.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.0 | GO:0097617 | annealing activity(GO:0097617) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 2.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.9 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 63.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 40.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.6 | 50.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.4 | 39.9 | PID ARF6 PATHWAY | Arf6 signaling events |
1.4 | 36.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.4 | 34.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.3 | 41.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.3 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.2 | 2.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.1 | 18.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.0 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 19.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.9 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.9 | 21.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.9 | 34.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 16.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.8 | 9.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 10.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 12.7 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 12.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 34.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 17.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 1.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 6.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 12.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 7.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.5 | 2.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 12.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 4.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 8.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 3.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 16.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 11.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 4.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 1.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 3.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 5.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 4.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 3.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 12.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 3.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 11.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 5.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 33.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 7.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 4.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 4.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 1.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 4.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 30.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 9.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 68.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
4.1 | 40.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
3.6 | 3.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.4 | 36.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
2.4 | 36.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 35.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.1 | 17.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.9 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.8 | 29.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.6 | 18.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.5 | 27.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.4 | 60.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.4 | 24.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.2 | 10.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 12.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.0 | 6.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.0 | 25.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 21.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.8 | 36.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.8 | 8.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 6.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.8 | 7.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 40.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 20.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 5.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 10.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 13.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 16.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 9.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 4.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 1.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 5.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 12.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 10.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 4.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 1.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 1.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.4 | 2.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 2.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 4.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 15.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 16.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 4.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 7.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 7.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 3.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 3.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 13.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 4.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 12.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 3.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 3.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 3.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 12.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 2.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 4.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 13.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 5.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 9.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 1.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 4.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 5.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 1.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 1.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 2.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 2.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 22.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 6.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 6.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 5.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 16.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 1.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.9 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 2.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |